Table 2.

Mean ADC-values for whole tumor volume for different treatment groups and days. Average ADC-values within ipsilateral tumor volumes were calculated for each animal before and compared with after treatment values. The same was done for contralateral tumor volumes. ANOVA with repeated measures followed by Holm-Sidak post-hoc test was used to determine if the differences in the mean ADC-values among different days of treatment are greater than the differences due to random sampling variability. Results are shown as mean±SD

ADC [10-3mm2/s]	-1 day	+1 day	+2 days	+3 days
IL13Rα2 T-cells (ipsilateral)	7.4±0.6	8.4±0.6	9.4±1.5 *	9.7±1.2 *
Non-specific T-cells (ipsilateral)	7.2±0.4	7.5±0.3	7.3±0.7	7.0±0.6
PBS (ipsilateral)	6.9±0.3	7.3±0.9	7.2±0.9	7.1±0.7
IL13Rα2 T-cells (contralateral)	7.1±0.7	7.3±0.7	7.2±0.8	6.8±0.6
Non-specific T-cells (contralateral)	7.9±0.8	7.7±0.6	7.5±0.3	6.7±0.3
PBS (contralateral)	6.8±0.5	7.4±1.1	7.1±0.6	7.4±1.3

^*p<0.05, data is given as mean±SD